ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Ultrasound Therapy for Fibromyalgia and Lyme Disease

Curcumin: The All In One Solution, Part 2

What Are the Benefits of Vitamin K2?

Vitamin D deficiency + high fat diet = metabolic syndrome

Why You Should Take Your Apple Cider Vinegar at Night

Use Burdock Oil to Promote Healthy Hair Growth

AMA journal associates iron deficiency with hearing loss

Meet Your Weight Loss Goals

People with forms of early-onset Parkinson's disease may benefit from boosting niacin in diet, resea...

Lutein linked to preservation of crystallized intelligence

 
Print Page
Email Article

FDA Approves First Blood Test to Predict Risk for Stroke

  [ 276 votes ]   [ Discuss This Article ]
www.ProHealth.com • June 17, 2005


Source: The Methodist Hospital HOUSTON, June 17, 2005 –

The U.S. Food and Drug Administration (FDA) approved today the first blood test designed to help predict a patient's risk for ischemic stroke, the most common type of stroke and one of the nation's leading causes of long-term disability affecting approximately 700,000 people per year. "This test provides a new tool to help us identify at-risk patients earlier, so we can start therapies in time to prevent a stroke altogether," said Christie Ballantyne, MD, director of the Center for Cardiovascular Disease Prevention at the Methodist DeBakey Heart Center in Houston.

The PLACTM test, developed by diaDexus, measures a blood enzyme called lipoprotein-associated phospholipase A2 (Lp-PLA2). Results from the National Heart Lung and Blood Institute's Atherosclerosis Risk in Communities (ARIC) study, conducted at the Methodist DeBakey Heart Center, demonstrated that people with elevated levels of this enzyme have a twofold risk of suffering an ischemic stroke associated with atherosclerosis over a period of 6 to 8 years. These findings are independent of traditional risk factors such as systolic blood pressure, smoking status and diabetes, body mass index, as well as levels of C-reactive protein (CRP), a risk factor for systemic inflammation.

While elevated cholesterol levels are a good predictor for heart disease, no such relationship has been established for stroke, even though both are related to blockages in blood vessels. "Unlike cholesterol levels, Lp-PLA2 was a significant and independent predictor of ischemic stroke in the ARIC study," Ballantyne said. "Current guidelines for screening and prevention of heart disease do not include risk for stroke. The PLAC test will help physicians more accurately predict who is at risk for stroke, so that the individual can take proactive and preventative measures, such as lifestyle modification or therapeutic intervention, including statins and daily aspirin." This study was supported by the National Institutes of Health (NIH) along with funding from GlaxoSmithKline.

About The Methodist Hospital The Methodist Hospital is one of the nation's largest private, non-profit general hospitals. Dedicated to providing the highest level of patient care, Methodist has a 90 year legacy of medical breakthroughs, such as the world's first multiple-organ transplant in the 1960s, gene therapy for prostate cancer, and the first islet cell transplants in Texas. U.S. News & World Report names Methodist among the country's top hospitals in nine specialties. Methodist is also home to The Methodist Hospital Research Institute, which is dedicated to accelerating the process of translating the best basic research into new treatments for diseases.

About the PLACTM Test The PLAC test, developed by diaDexus, Inc., was originally cleared by the FDA as an aid in predicting an individual's risk for coronary heart disease in July 2003. It is now cleared to aid in the prediction of an individual's risk for a coronary event and ischemic stroke associated with atherosclerosis, in conjunction with clinical evaluation and patient risk assessment. The PLAC test is currently available through laboratories nationwide, including Quest Diagnostics Incorporated, Mayo Medical Laboratories, ARUP Laboratories and Berkeley HeartLab.



Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Energy NADH™ 12.5mg Ultra ATP+, Double Strength

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid

Natural Remedies

Natural Bladder Control, Go Less and Live More Natural Bladder Control, Go Less and Live More
D-ficient? Health Risks You Need to Know About D-ficient? Health Risks You Need to Know About
Three-Step Strategy to Reverse Mitochondrial Aging Three-Step Strategy to Reverse Mitochondrial Aging
Secret Nutrient for Radiant Skin Secret Nutrient for Radiant Skin
How to Jump-start and Sustain Energy Production in CFS How to Jump-start and Sustain Energy Production in CFS

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map